FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ian Pullar

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Co-author Network

Publications

TOP 3
Ian A Pullar; John Boot; Richard J Broadmore; Tina A Eyre; Jane Cooper; Graham J Sanger; Susan Wedley; Stephen N Mitchell
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
Graham H Timms; John Boot; Richard J Broadmore; Stepheb Carney; Jane Cooper; Jeremy D Findlay; Jeremy Gilmore; Stephen Mitchell; Nicholas Moore; Ian A Pullar; Graham J Sanger; Rosemarie Tomlinson; Beverly B Tree; Susan Wedley
SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis.
Lorraine Axford; John Boot; Terrence M Hotten; Martine Keenan; Fionna M Martin; Sandra Milutinovic; Nicholas Moore; Michael F O'Neill; Ian A Pullar; David E Tupper; Kristel R Van Belle; Vincent Vivien
Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ian Pullar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Ian A Pullar; John Boot; Richard J Broadmore; Tina A Eyre; Jane Cooper; Graham J Sanger; Susan Wedley; Stephen N Mitchell
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
European journal of pharmacology 2004;493(1-3):85-93.
2004: Graham H Timms; John Boot; Richard J Broadmore; Stepheb Carney; Jane Cooper; Jeremy D Findlay; Jeremy Gilmore; Stephen Mitchell; Nicholas Moore; Ian A Pullar; Graham J Sanger; Rosemarie Tomlinson; Beverly B Tree; Susan Wedley
SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis.
Bioorganic & medicinal chemistry letters 2004;14(10):2469-72.
2003: Lorraine Axford; John Boot; Terrence M Hotten; Martine Keenan; Fionna M Martin; Sandra Milutinovic; Nicholas Moore; Michael F O'Neill; Ian A Pullar; David E Tupper; Kristel R Van Belle; Vincent Vivien
Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.
Bioorganic & medicinal chemistry letters 2003;13(19):3277-80.
2003: Julian Goggi; Ian A Pullar; Stepheb Carney; Henry F Bradford
Signalling pathways involved in the short-term potentiation of dopamine release by BDNF.
Brain research 2003;968(1):156-61.
2003: Julian Goggi; Ian A Pullar; Stepheb Carney; Henry F Bradford
The control of [125I]BDNF release from striatal rat brain slices.
Brain research 2003;967(1-2):201-9.
2002: Julian Goggi; Ian A Pullar; Stepheb Carney; Henry F Bradford
Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro.
Brain research 2002;941(1-2):34-42.
2001: Ian A Pullar; John Boot; Stepheb Carney; M L Cohen; E M Colvin; R G Conway; C H Hardy; V L Lucaites; D L Nelson; K W Schenck; Rosemarie Tomlinson; Susan Wedley
In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
European journal of pharmacology 2001;432(1):9-17.
2000: Ian A Pullar; Stepheb Carney; E M Colvin; V L Lucaites; D L Nelson; Susan Wedley
LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone.
European journal of pharmacology 2000;407(1-2):39-46.